tilization of a portable hand-held electrocardiogram (ECG) monitor for mapping normal heart signals to investigate the optimal placement of insertable cardiac monitors for patient having heart rhythm disorders investigated.

Not Applicable

Recruiting

• Conditions: Cardiac Rhythm Disorders; Cardiovascular - Other cardiovascular diseases

• Registration Number: ACTRN12620000140954
• Lead Sponsor: Dr Dennis Lau

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-02-12
• Last Update Posted: 20 June 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

•Participant must be in sinus rhythm (cardiology inpatients will have telemetry ward monitoring to allow rhythm identification for inclusion).
•Cardiac situs solitus.
•Greater than or equal to 18 years of age.
•Able to provide consent.

Exclusion Criteria

•Unable to provide written informed consent to participate in this study.
•Participating in another clinical research trial which prevents acquisition of surface ECG.
•Cardiac situs inversus or other abnormal cardiac gross displacement.
•Participant not in sinus rhythm.
•Known allergic reaction to ECG electrode dots.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in p-wave amplitude as assessed by ECG with different electrode vector spacing . [This is a single point data collection study with no intervention and follow-up requirement. All measurements will be pooled at completion of recruitment for analysis.]

Secondary Outcome Measures

Name	Time	Method
Change in p-wave amplitude as assessed by ECG with different angle of electrode vector.[This is a single point data collection study with no intervention and follow-up requirement. All measurements will be pooled at completion of recruitment for analysis.];Change in p-wave amplitude for different physical body composition, assessed by BMI and body fat percentage calculated by Omron Fat Loss Monitor (HBF-306)[This is a single point data collection study with no intervention and follow-up requirement. All measurements will be pooled at completion of recruitment for analysis.]